Berlin/Aalborg, 27 October 2022. The University Hospital Aalborg (Denmark) yesterday has imaged the first patient with Eckert and Ziegler’s Gallium (68Ga) boclatixafortide (PENTIXAFOR) in an international phase 2 trial.

The IMAG1NE Phase 1/2 trial is an accelerated dose-titration, open-label, multi-center Phase 1/2 trial to evaluate TK-8001 in patients with MAGE-A1 positive solid tumors

TK-8001 targets a MAGE-A1 epitope presented on HLA-A*02:01

IMAG1NE…

Berlin, Germany and Stockholm, Sweden, October 20, 2022:

FyoniBio, a CDO expert specialized in tailored cell line development and Strike Pharma, whose proprietary

Adaptable Drug Affinity Conjugate (ADAC) technology enables development of …

The term “Long COVID” first emerged in the social media. Numerous affected individuals have reported in the social media about their various, long-lasting health limitations after SARS-CoV-2 infection. In the Berlin-Brandenburg metropolitan region,…

pharmtrace, a German, Berlin based provider of Independent expertise for nuclear medicine, diagnostics, and drug development clinical trials has established a representative office in Philadelphia. pharmtrace is currently enjoying increasing…